Skip to main content
Journal cover image

Age-Related Divergence of Risk-Benefit Relationship of Spironolactone Treatment for Heart Failure With Preserved Ejection Fraction.

Publication ,  Journal Article
Kitzman, DW; Upadhya, B
Published in: JACC Heart Fail
December 2019

Duke Scholars

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

December 2019

Volume

7

Issue

12

Start / End Page

1029 / 1031

Location

United States

Related Subject Headings

  • Stroke Volume
  • Spironolactone
  • Risk Assessment
  • Mineralocorticoid Receptor Antagonists
  • Humans
  • Heart Failure
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kitzman, D. W., & Upadhya, B. (2019). Age-Related Divergence of Risk-Benefit Relationship of Spironolactone Treatment for Heart Failure With Preserved Ejection Fraction. JACC Heart Fail, 7(12), 1029–1031. https://doi.org/10.1016/j.jchf.2019.09.006
Kitzman, Dalane W., and Bharathi Upadhya. “Age-Related Divergence of Risk-Benefit Relationship of Spironolactone Treatment for Heart Failure With Preserved Ejection Fraction.JACC Heart Fail 7, no. 12 (December 2019): 1029–31. https://doi.org/10.1016/j.jchf.2019.09.006.
Kitzman, Dalane W., and Bharathi Upadhya. “Age-Related Divergence of Risk-Benefit Relationship of Spironolactone Treatment for Heart Failure With Preserved Ejection Fraction.JACC Heart Fail, vol. 7, no. 12, Dec. 2019, pp. 1029–31. Pubmed, doi:10.1016/j.jchf.2019.09.006.
Journal cover image

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

December 2019

Volume

7

Issue

12

Start / End Page

1029 / 1031

Location

United States

Related Subject Headings

  • Stroke Volume
  • Spironolactone
  • Risk Assessment
  • Mineralocorticoid Receptor Antagonists
  • Humans
  • Heart Failure
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology